Advanced searches left 3/3

Peripheral Neuropathy - PubAg

Summarized by Plex Scholar
Last Updated: 15 October 2021

* If you want to update the article please login/register

Mechanisms of Venoarteriolar Reflex in Type 2 Diabetes with or without Peripheral Neuropathy

The aim of this research study is to investigate the underlying mechanisms of the venoarteriolar reflex in type 2 diabetes mellitus, with and without peripheral neuropathy. Laser Doppler flowmetry recordings were carried out on the medial malleus and dorsal foot skin, prior to and throughout leg dependence in healthy and balanced controls, personallies with weight problems, in those with T2DM, in those with T2DM and subclinical neuropathy, and in those with T2DM and verified neuropathy. Skin blood perfusion lowered throughout leg dependency at both sites.

Source link: https://pubag.nal.usda.gov/catalog/7350896


Acrylamide-induced peripheral neuropathy: manifestations, mechanisms, and potential treatment modalities

Acrylamide is a chemical monomer; its polymer compounds are used in the manufacture of plastic, papers, sticky tapes, dyes, and food packaging. Lately, scientists located that food preparation returns acrylamide. In enhancement to fried/baked potatoes, coffee and bakery products still include significant amounts of acrylamide. Acrylamide has hazardous effects on various body systems consist of genitourinary, reproductive, nerves, together with being a cancer causing substance. The neurotoxicity of acrylamide consists of peripheral and central neuropathy. The suggested mechanisms for acrylamide neurotoxicity include straight inhibition of neurotransmission, cellular adjustments, inhibition of key cellular enzymes, and bonding of kinesin-based quick axonal transport. Furthermore, it is suggested that acrylamide's molecular impact on SNARE core kinetics is lugged out with the adduction of NSF and/or SNARE proteins. Recently, scientists showed interruption of focal adhesion kinase and proline-rich tyrosine kinase 2 cell signaling paths in human differentiating neuroblastoma SH-SY5Y cells, revealed to acrylamide.

Source link: https://pubag.nal.usda.gov/catalog/7303866


A systematic review on the efficacy of vitamin D supplementation on diabetic peripheral neuropathy

Vitamin D deficiency is recognized to be widespread in patients with diabetes and in particular in those having signs and symptoms of diabetic person peripheral neuropathy. Hence, it is worthwhile to investigate whether a supplementation of vitamin D would improve discomfort among those having diabetes mellitus and DN. An organized literature search was performed to identify studies that reported the influence of vitamin D supplements on the signs and signs of DN. Meta-analytical outcomes were as follows: Serum Vitamin D degree modification of 1. 39, HbA1c modification of 0. 134, McGill Pain Questionnaire rating of 1. 14, done in favor of the vitamin D supplements team. Discomfort improvement was not correlated to standard or adjustment in lotion vitamin D level. Vitamin D supplements might be an added value in the treatment of unpleasant peripheral diabetic neuropathy. Amelioration hurting may be associated with the absolute value of vitamin D obtained following supplementation.

Source link: https://pubag.nal.usda.gov/catalog/6835590


Jinmaitong ameliorates diabetes-induced peripheral neuropathy in rats through Wnt/β-catenin signaling pathway

Jinmaitong is a prescription of Traditional Chinese Medicine, which is composed of 10 natural drugs and 2 animal medications. This research aims to evaluate the safety result of JMT versus DPN dynamically during a 16-weeks' treatment, and to investigate the underlying mechanism in which the Wnt/ β-catenin path is involved. Diabetic model was induced by solitary intraperitoneal shot of Streptozotocin making use of male Sprague-Dawley rats. The reduced MPZ level in DPN rats were additionally substantially changed by JMT. We located that the reduced Wnt/ β-catenin path in sciatic nerves of DPN rats was overtly up-regulated by JMT in a time-dependent manner. Amongst the 3 doses, JMT at the center dosage showed the ideal effect. JMT efficiently alleviated diabetic-induced peripheral neuropathy, which was mediated by the activation of Wnt/ β-catenin signaling pathway.

Source link: https://pubag.nal.usda.gov/catalog/7139106


Behavior and electrophysiology studies of the peripheral neuropathy induced by individual and co-administration of paclitaxel and oxaliplatin in rat

The objective of today research study is to contrast the neuropathic signs induced by individual or mixed administration of paclitaxel and oxaliplatin. Oxaliplatin and paclitaxel were carried out independently and integrated to cause peripheral neuropathy in rats, sensory neuropathic signs were assessed in the hind limbs and orofacial area. Aδ-fibers of the rats treated with the combination were hyperexcited and offered hypersensitivity to pressure stimulation of the innervated skin, also similar to that tape-recorded in the fibers of the pets treated with monotherapy. Our work objectively shows that the combination of a platinum substance with a taxane does not aggravate the growth of sensorial neuropathies in rats, which is a fascinating information to take into account when the combination of antitumor medications is essential. Co-administration of antitumor medicines is a lot more efficient in cancer treatment without raising the threat of the disabling neuropathic side effects.

Source link: https://pubag.nal.usda.gov/catalog/7326972


The mechanisms of glycemic variability accelerate diabetic central neuropathy and diabetic peripheral neuropathy in diabetic rats

The effect of glycemic variability on diabetic person neuropathy, including diabetic central neuropathy and diabetic peripheral neuropathy, and the entailed mechanism are not fully comprehended. To assess DPN, the motor nerve transmission speed was gauged, and the microstructure of the sciatic nerve was observed. Furthermore, GV damaged the MNCV of the sciatic nerve, and the frameworks of both the myelin sheath and the axons in the sciatic nerve were interrupted. GV additionally significantly reduced the expression of superoxide dismutase and enhanced the expression degrees of malondialdehyde, of proinflammatory cytokines and of NF-κB. In final thought, today research study highlighted that GV could induce diabetic central neuropathy via the hyperphosphorylation of Tau in the hippocampus by inhibiting the Akt/GSK3 β pathway which it may trigger DPN via oxidative anxiety and inflammatory responses by activating the NF-κB path.

Source link: https://pubag.nal.usda.gov/catalog/6280605


Beneficial effects of nano‐curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: A randomized, double‐blind, placebo‐controlled clinical trial

Depression in patients with diabetes is connected with inadequate glycemic control and linked to a raised danger for diabetes issues such as neuropathy. Curcumin has shown potential antidepressant‐like tasks in some studies. The present research study is the first randomized controlled trial to test the effectiveness of nano‐curcumin supplementation on clinical depression, anxiety, and stress in patients with diabetic person polyneuropathy. The clinical depression, anxiety, and stress degree were determined by Depression, Anxiety, Stress Scale set of questions prior to and after the treatment. After intervention, there was a substantial decrease in the mean score of anxiety in the nano‐curcumin group contrasted with placebo team. On top of that, a significant fall was discovered in the mean rating of anxiety in the nano‐curcumin team compared to the placebo team. These searchings for recommended that nano‐curcumin supplements for 8 weeks worked in decreasing anxiety and stress and anxiety scores in patients with diabetic person polyneuropathy.

Source link: https://pubag.nal.usda.gov/catalog/6884693


Escin alleviates peripheral neuropathy in streptozotocin induced diabetes in rats

Inflammatory cascade and oxidative tension play a central function in diabetic peripheral neuropathy using activation of inflammatory cytokines. The present research was conducted to examine the result of escin on diabetic peripheral neuropathy in streptozotocin induced diabetes mellitus in rats. Diabetes was generated in rats with streptozotocin. The animals with blood sugar over 250 mg/dl were randomized in various groups. Pets were treated with escin at a dose of 5, 10 and 20 mg/kg after 6 weeks of diabetic issues induction for the next 4 weeks. The motor nerve transmission speed and sensory nerve transmission rates were significantly enhanced in diabetic pets treated with escin. Escin treatment stopped development of neuronal damages by reducing demyelination, leukocytic infiltration in sciatic nerves as compared to diabetic animals. From the outcomes of research study it can be wrapped up that escin can be a beneficial choice for management of diabetic person peripheral neuropathy.

Source link: https://pubag.nal.usda.gov/catalog/6968748


Vitamin D and rosuvastatin obliterate peripheral neuropathy in a type-2 diabetes model through modulating Notch1, Wnt-10α, TGF-β and NRF-1 crosstalk

Vitamin D and rosuvastatin are well-known medicines that moderate valuable impacts in treating type-2 diabetes mellitus complications; nonetheless, their anti-neuropathic capacity is debatable. Hence, our research study explores their neurotherapeutic possibility and the feasible hidden mechanisms utilizing a T2D-associated neuropathy rat model. Diabetic peripheral neuropathy was induced with 8 weeks of administration of a high fat fructose diet complied with by a solitary i. p. injection of streptozotocin. 6 weeks later, DPN created and rats were separated into five groups; viz. , control, without treatment DPN, DPN treated with vitamin D, DPN treated with rosuvastatin, or DPN treated with combination vitamin D and rosuvastatin. We established their anti-neuropathic results on small nerves; huge nerves; neuronal inflammation; apoptosis; mitochondrial function; and NICD1, Wnt-10α/ β-catenin, and TGF-β/ Smad-7 pathways. Two-month treatment with vitamin D and/or rosuvastatin regrowed neuronal function and style and eased off neuronal inflammation and apoptosis.

Source link: https://pubag.nal.usda.gov/catalog/7409966


Compound XiongShao Capsule ameliorates streptozotocin-induced diabetic peripheral neuropathy in rats via inhibiting apoptosis, oxidative - nitrosative stress and advanced glycation end products

Rats with DPNinduced by streptozotocin/high-fat diet regimen for 4 weeks were treated with CXSC at three dosages, or epalrestat daily for 8 weeks continually. The product levels of sophisticated glycation final product, oxidative-- nitrosative stress and anxiety biomarkers of superoxide dismutase, and nitric oxide synthase were gauged utilizing a rat-specific ELISA kit. CXSC had no considerable impact on body weight or lotion glucose degrees, but it significantly enhanced mechanical hyperalgesia F ₅, ₃₆ = 18. 24, P.

Source link: https://pubag.nal.usda.gov/catalog/7173756

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions